Category: Biotech & MedTech
-
Voyageur Pharmaceuticals Ltd. Completes Medical Imaging CT Contrast Agent Production Testing and Begins Production Scale-up of SmoothX (TM)
November 28, 2022 (Source) – Voyageur Pharmaceuticals Ltd. (TSXV:VM) (OTC:VYYRF) (the “Company” or “Voyageur”) announces completion of the production test…
-
Valeo Pharma Announces Senior Management Change
Valeo’s President and Chief Operating Officer steps down and will continue as special advisor and member of the…
-
Hemostemix Thanks Six-Time Grammy Award Winner, Howie Lindeman, for his ACP-01 Testimonial Interview
November 17, 2022 (Source) – Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) (“Hemostemix” or the “Company”) is…
-
Sixth Wave Enters into Secured Note Agreement
November 16, 2022 (Source) – Sixth Wave Innovations Inc. (CSE: SIXW) (OTCQB: SIXWF) (FSE: AHUH) (“Sixth Wave” or…
-
Hemostemix Announces Advancements in Its Automation of Production
November 15, 2022 (Source) – Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) (“Hemostemix” or the “Company”) is…
-
Valeo Pharma Raises Q4 and Full Year 2022 Revenue Guidance
Q4-2022 revenue guidance raised to a record $12.5M – $13.0M Fiscal 2022 revenue guidance increased to a record $27.5M – $28.0M November 15, 2022…
-
Cardiol Therapeutics Receives Nasdaq Deficiency Notice Regarding Minimum Bid Price Requirement
November 14, 2022 (Source) – Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) (“Cardiol” or the “Company”), a clinical-stage life sciences…
-
Sona Signs MOU for Bovine TB Test Development and Commercialization
This news release constitutes a “designated news release” for the purposes of the Company’s prospectus supplement dated April…
-
Cardiol Therapeutics Announces Study Results Demonstrating Protective Effects of CardiolRx(TM) in a Model of Acute Pericarditis
Results Demonstrate Significant Reduction in Pericardial Effusion and Thickness and Significant Suppression of Key Inflammatory Markers IL-1β and…
-
Zentek Files Amended and Restated Audited Financial Statements
November 4, 2022 (Source) – Zentek Ltd. (“Zentek” or the “Company”) (NASDAQ:ZTEK)(TSXV:ZEN), announces that it has filed amended and restated…
